Prebiomics
PreBiomics leverages top-level expertise and scientific knowledge to provide innovative tools and services for personalized wellness strategies in the clinical human microbiome field. Their business model focuses on advanced microbiome testing and analysis, particularly through their flagship product, the PreBiomics Implant Test™, which aims to revolutionize the prevention and treatment of dental implant diseases. With over 200,000 biological samples analyzed in the last two years and more than 80 customers served in the past year, PreBiomics is positioned as a leader in the microbiome analysis market, emphasizing scientific research and innovation.
Prebiomics
PreBiomics leverages top-level expertise and scientific knowledge to provide innovative tools and services for personalized wellness strategies in the clinical human microbiome field. Their business model focuses on advanced microbiome testing and analysis, particularly through their flagship product, the PreBiomics Implant Test™, which aims to revolutionize the prevention and treatment of dental implant diseases. With over 200,000 biological samples analyzed in the last two years and more than 80 customers served in the past year, PreBiomics is positioned as a leader in the microbiome analysis market, emphasizing scientific research and innovation.
TL;DR
Founded: 2017
Headquarters: Trento, Italy
Core offering: AI-powered metagenomics and high-throughput NGS services (including oral-health Implant Test)
Lab capacity: Production-scale NGS facility with NovaSeq platforms
Samples analysed: Over 200,000 biological samples (last two years)
Company Overview
Problem Domain
Clinical human microbiome analysis and precision oral-health diagnostics
Founded
2017
Industry
Biotechnology
Tech Stack
Funding Track Record
Announced May 30, 2019; closed Nov 30, 2019 per company funding records